Aptadel Therapeutics
A biotech company focused on the development of cancer treatment based on aptamer technology.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD10—15m (Dealroom.co estimates Jan 2021.)
Company register number B02925824
Barcelona Catalonia (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
€1.7m | Seed | ||
Total Funding | CAD2.6m |
Related Content
Recent News about Aptadel Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.